Tulip BioMed™, Inc., formerly known as Cell Bio-Systems, Inc. (PINKSHEETS: CBSI), a developer of medical devices and patented technologies for the living tissue markets, including plastic, cosmetic, and orthopedic surgeries, today announced it has begun shipping its new disposable surgical instruments for the removal of soft tissue and fluid for the plastic surgery market. The company received U.S. Food and Drug Administration (FDA) 510(k) clearance for its cannula devices in early May.
